Skip to content

New Owner

Illumina - Epicentre Biotechnologies

Illumina acquires Epicentre Biotechnologies

Announced: January 01, 2011

Type:           Acquisition
Terms:         Cash & Stock
Status:         Pending

Amount:       $ 90,000,000

Acquisition News

Add News

Date Title
Mar 08, 2011 genomeweb.com - Illumina Paying up to $90M in Cash and Stock in Epicentre Acquisition
Illumina Paying up to $90M in Cash and Stock in Epicentre Acquisition
Jan 12, 2011 Reuters - Illumina Acquires Epicentre Biotechnologies, Leading Provider of Nucleic Acid Sample Preparation Reagents and Specialty Enzymes
Illumina Acquires Epicentre Biotechnologies, Leading Provider of Nucleic Acid Sample Preparation Reagents and Specialty Enzymes

Illumina Other Acquisitions

Add Acquisition

Date Acquired Amount
Jan 27, 2016
Conexio Genomics
Undisclosed amount
Aug 04, 2015
GenoLogics
Undisclosed amount
Oct 28, 2013
NextBio
Undisclosed amount
Jul 23, 2013
Advanced Liquid Logic
$ 96,000,000
Jan 07, 2013
Verinata Health
$ 350,000,000
Sep 19, 2012
BlueGnome
Undisclosed amount
View more acquisitions »